Add Company
Join Now

NAPIGEN Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NAPIGEN's estimated annual revenue is currently $1.4M per year.(i)
  • NAPIGEN's estimated revenue per employee is $77,500

Employee Data

  • NAPIGEN has 18 Employees.(i)
  • NAPIGEN grew their employee count by 20% last year.

NAPIGEN's People

NameTitleEmail/Phone
1
CEO & Co-founderReveal Email/Phone
2
President & CEO, Co-FounderReveal Email/Phone
3
Research Director - Plant GeneticsReveal Email/Phone
4
Director, Product DevelopmentReveal Email/Phone
5
Administrative ManagerReveal Email/Phone
6
Greenhouse ManagerReveal Email/Phone
7
Research FellowReveal Email/Phone
8
Research ScientistReveal Email/Phone
9
Sr Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$79.1M5100%N/AN/A
#2
$0.9M620%N/AN/A
#3
$1.9M129%N/AN/A
#4
$5.4M3521%N/AN/A
#5
$0.8M5-29%N/AN/A
#6
$8.7M5624%N/AN/A
#7
$1.4M9-31%N/AN/A
#8
$1.1M70%N/AN/A
#9
$36M23219%N/AN/A
#10
$15.5M100-2%N/AN/A
Add Company

What Is NAPIGEN?

NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes and animals. Our technology targets two special cellular components known as organelles that harbor their own DNA. Those organelles are called mitochondria and chloroplasts. Both organelles are important to create energy for cells to grow. They are also critical for producing various biochemical molecules key to specific pathways and functions. Our genome technology has broad application areas. They range from industrial biotechnology to animal and human healthcare as well as to agriculture. Our mission is to harness the potentials of organelles to make our society a better place to live.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$1.4M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.9M180%N/A
#2
$1.6M1813%N/A
#3
$2.2M1820%N/A
#4
$2.2M18N/AN/A
#5
$1.6M18-10%N/A